IL123040A0 - Manganese complexes pharmaceutical compositions containg them and their use - Google Patents

Manganese complexes pharmaceutical compositions containg them and their use

Info

Publication number
IL123040A0
IL123040A0 IL12304096A IL12304096A IL123040A0 IL 123040 A0 IL123040 A0 IL 123040A0 IL 12304096 A IL12304096 A IL 12304096A IL 12304096 A IL12304096 A IL 12304096A IL 123040 A0 IL123040 A0 IL 123040A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
manganese complexes
compositions containg
containg
complexes
Prior art date
Application number
IL12304096A
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of IL123040A0 publication Critical patent/IL123040A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D259/00Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials
IL12304096A 1995-08-17 1996-08-14 Manganese complexes pharmaceutical compositions containg them and their use IL123040A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US242195P 1995-08-17 1995-08-17
PCT/US1996/012767 WO1997006824A2 (en) 1995-08-17 1996-08-14 Bioconjugates of manganese complexes and their application as catalysts

Publications (1)

Publication Number Publication Date
IL123040A0 true IL123040A0 (en) 1998-09-24

Family

ID=21700675

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12304096A IL123040A0 (en) 1995-08-17 1996-08-14 Manganese complexes pharmaceutical compositions containg them and their use

Country Status (12)

Country Link
EP (1) EP0844886A2 (en)
JP (1) JP2000513322A (en)
KR (1) KR19990037647A (en)
CN (1) CN1200039A (en)
AU (1) AU700958B2 (en)
BR (1) BR9610347A (en)
CA (1) CA2229799A1 (en)
CZ (1) CZ39898A3 (en)
IL (1) IL123040A0 (en)
NO (1) NO980649L (en)
PL (1) PL324993A1 (en)
WO (1) WO1997006824A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2254142T3 (en) 1999-01-25 2006-06-16 National Jewish Medical And Research Center REPLACED PORPHIRINS AND THEIR THERAPEUTIC USE.
US6749832B2 (en) 1999-12-23 2004-06-15 Amersham Plc Labelled ascorbic acid derivatives
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
EP1439842A4 (en) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
KR20140001257A (en) 2008-05-13 2014-01-06 유니버시티 오브 캔사스 Metal abstraction peptide(map) tag and associated methods
RU2506083C2 (en) 2008-05-23 2014-02-10 Нэшнл Джуиш Хелт Method of treating disorders associated with alkylating agent exposure
CN103906756B (en) * 2011-09-26 2020-03-03 加莱拉实验室有限责任公司 Methods for treating diseases
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
AU2018221043A1 (en) * 2017-02-15 2019-09-12 Galera Labs, Llc Pentaaza macrocyclic ring complexes for local intestinal delivery
CN108752383B (en) * 2018-05-02 2020-10-30 江苏理工学院 Pyrazole carboxylate manganese complex with SOD activity and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281463A3 (en) * 1987-03-06 1989-01-25 Sumitomo Pharmaceuticals Company, Limited Platinum complex, process for its preparation and pharmaceutical composition including such a complex
ATE164164T1 (en) * 1991-07-19 1998-04-15 Monsanto Co MANGANEOUS COMPLEXES WITH NITROGEN-CONTAINING MACROCYCLIC LIGANDS, ACTIVE AS SUPEROXIDE DISMUTASE CATALYSTS.
US6204259B1 (en) * 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
CN1152880A (en) * 1994-04-22 1997-06-25 孟山都公司 Diagnostic image analysis with metal complexes
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
AU5928396A (en) * 1995-06-07 1996-12-30 Monsanto Company Process for preparing substituted polyazamacrocycles

Also Published As

Publication number Publication date
WO1997006824A2 (en) 1997-02-27
EP0844886A2 (en) 1998-06-03
CA2229799A1 (en) 1997-02-27
AU700958B2 (en) 1999-01-14
MX9801322A (en) 1998-05-31
JP2000513322A (en) 2000-10-10
BR9610347A (en) 1999-06-01
AU6765596A (en) 1997-03-12
NO980649L (en) 1998-04-02
NO980649D0 (en) 1998-02-16
WO1997006824A3 (en) 1997-07-03
CN1200039A (en) 1998-11-25
CZ39898A3 (en) 1998-07-15
PL324993A1 (en) 1998-07-06
KR19990037647A (en) 1999-05-25

Similar Documents

Publication Publication Date Title
IL122485A0 (en) Arylsulfonylaminobenzene derivatives and pharmaceutical compositions containg the same
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
HUP9800792A3 (en) Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same
IL117962A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
HUP0004398A3 (en) Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
HUP9900424A2 (en) Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
HUP9602196A3 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
IL123040A0 (en) Manganese complexes pharmaceutical compositions containg them and their use
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
IL120637A0 (en) Retinoids their preparation and pharmaceutical compositions containing them
IL115982A0 (en) Cyclolignan derivatives and pharmaceutical compositions containing the same
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
IL113415A0 (en) Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
IL117618A0 (en) Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same
IL115882A0 (en) Oxazolyl-and thiazolylimidazo-benzo-and thienodiazepines their manufacture and pharmaceutical compositions containing them
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them